Materialise NV Q3 2025 Earnings Recap

MTLS Q3 2025 October 28, 2025

Get alerts when MTLS reports next quarter

Materialise reported third-quarter earnings with robust growth in its medical unit, buoyed by advancements in cardiac technology, despite overall revenue remaining under pressure.

Earnings Per Share Beat

$0.04 vs $0.01 est.

+300.0% surprise

Revenue Beat

77795000 vs 70730000 est.

+10.0% surprise

Market Reaction

1-Day -4.04%

5-Day +7.74%

30-Day +0.51%

See MTLS alongside your other holdings

Add to your portfolio — free

Key Takeaways

Medical unit achieved double-digit growth, driven by innovative product launches and clinical evidence.
Acquisition of FEops enhances capabilities in AI-driven heart intervention simulations, improving procedural efficiency.
New versions of existing software, including Mimics Enlight CMF, integrate AI for faster and more accurate surgical planning.
Continued progress in establishing CO-AM as a comprehensive ecosystem for additive manufacturing operations, supporting scalability and efficiency.
Anticipation builds for upcoming presentations at Formnext, highlighting advancements and product capabilities.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit MTLS on AllInvestView.

Previous Q2 2025

Next Q1 2026